Rote William E. (CIK 0001698262)

Latest company ownership

TVTX - Travere Therapeutics, Inc.
Role: Chief Research Officer
Shares held
4,920
Last filed at
May 5, 2025
Confidence Score
49.8
2025Q4
Confidence Score History
2018Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 2, 2025 May 5, 2025 Travere Therapeutics, Inc. Chief Research Officer Sell 37.5 -3,198 -3.09% ✓ $67.3K
Feb 10, 2025 Feb 12, 2025 Travere Therapeutics, Inc. President Sell 32.5 -5,200 -5.01% ✓ $122.4K
Jan 31, 2025 Feb 4, 2025 Travere Therapeutics, Inc. President Sell 95.0 +12,549 15.09% ✓ $177.1K
Jan 22, 2025 Jan 23, 2025 Travere Therapeutics, Inc. President Sell 45.0 -2,437 -2.85% ✓ $47.4K
Sep 5, 2024 Sep 9, 2024 Travere Therapeutics, Inc. President Sell 87.5 +2,363 2.88% ✓ $50.5K
Jan 31, 2024 Feb 2, 2024 Travere Therapeutics, Inc. President Sell 91.3 +20,236 33.46% ✓ $41.5K
Jan 23, 2024 Jan 25, 2024 Travere Therapeutics, Inc. President Sell 41.3 -2,062 -3.30% ✓ $18.5K
Aug 31, 2023 Sep 5, 2023 Travere Therapeutics, Inc. President Sell 78.8 +1,485 2.49% ✓ $26.7K
May 10, 2023 May 12, 2023 Travere Therapeutics, Inc. President Sell 48.8 -825 -1.37% ✓ $13.7K
Jan 31, 2023 Feb 2, 2023 Travere Therapeutics, Inc. President Sell 95.0 +17,660 41.67% ✓ $57.6K
Jan 24, 2023 Jan 26, 2023 Travere Therapeutics, Inc. President Sell 41.3 -2,062 -4.64% ✓ $44.3K
May 11, 2022 May 12, 2022 Travere Therapeutics, Inc. President Sell 41.3 -1,563 -3.46% ✓ $33.9K
Jan 31, 2022 Feb 2, 2022 Travere Therapeutics, Inc. President Sell 91.3 +8,715 23.86% ✓ $30.8K
Jan 24, 2022 Jan 26, 2022 Travere Therapeutics, Inc. President Sell 41.3 -1,875 -4.88% ✓ $46.8K
Jan 10, 2022 Jan 12, 2022 Travere Therapeutics, Inc. President Sell 90.0 +2,500 6.96% ✓ $68.5K
Aug 13, 2021 Aug 17, 2021 Travere Therapeutics, Inc. President Sell 86.3 +3,093 9.48% ✗ $24.1K
May 11, 2021 May 13, 2021 Travere Therapeutics, Inc. President Sell 28.8 -3,125 -8.97% ✓ $60.3K
Feb 17, 2021 Feb 18, 2021 Travere Therapeutics, Inc. President Sell 32.5 -2,500 -6.70% ✓ $70K
Feb 5, 2021 Feb 9, 2021 Travere Therapeutics, Inc. President Sell 25.0 -4,500 -10.76% ✓ $141.7K
Feb 3, 2021 Feb 3, 2021 Travere Therapeutics, Inc. President Sell 28.8 -3,625 -8.85% ✓ $104.8K
Jan 31, 2021 Feb 2, 2021 Travere Therapeutics, Inc. President Sell 82.5 +1,375 1.08% ✓ $111.5K
Nov 16, 2020 Nov 17, 2020 Travere Therapeutics, Inc. President Sell 28.8 -2,500 -9.40% ✓ $59.9K
Nov 11, 2020 Nov 13, 2020 Travere Therapeutics, Inc. President Sell 95.0 +2,500 10.38% ✓ $59.1K
Sep 23, 2020 Sep 23, 2020 Travere Therapeutics, Inc. President Sell 36.3 -1,500 -5.86% ✓ $27.7K
Sep 18, 2020 Sep 22, 2020 Travere Therapeutics, Inc. President Sell 86.3 +1,500 6.23% ✓ $27.9K
May 11, 2020 May 13, 2020 Travere Therapeutics, Inc. President Sell 32.5 -2,152 -8.39% ✓ $35K
Mar 10, 2020 Mar 12, 2020 Travere Therapeutics, Inc. President Sell 28.8 -3,250 -11.25% ✓ $48.3K
Feb 14, 2020 Feb 19, 2020 Travere Therapeutics, Inc. President Sell 32.5 -2,500 -8.88% ✓ $41.6K
May 14, 2019 May 16, 2019 Travere Therapeutics, Inc. President Sell 32.5 -1,625 -8.20% ✓ $28.9K
Feb 15, 2019 Feb 20, 2019 Travere Therapeutics, Inc. President Sell 20.0 -2,500 -15.33% ✓ $53.7K
Feb 11, 2019 Feb 13, 2019 Travere Therapeutics, Inc. President Sell 28.8 -1,985 -11.03% ✓ $42.6K
Nov 14, 2018 Nov 16, 2018 Travere Therapeutics, Inc. President Sell 15.0 -5,000 -21.75% ✓ $120.1K
Feb 14, 2018 Feb 16, 2018 Travere Therapeutics, Inc. President Sell 26.3 -1,034 -8.48% ✗ $22.2K